BRIEF published on 03/14/2024 at 14:20, 1 year 8 months ago Anglepoint Achieves Verified Partner Status in Oracle Software Asset Management Program AngelPoint Oracle Software Asset Management License Optimization Oracle SAM Program
PRESS RELEASE published on 03/14/2024 at 14:15, 1 year 8 months ago Anglepoint is Now a Verified Partner in the New Oracle Software Asset Management Program Anglepoint, a Verified SAM (VSAM) Partner, is now recognized by Oracle to offer license optimization services for Oracle Database, Middleware, and E-business Suite within the Oracle SAM Program Oracle License Optimization Anglepoint Verified SAM Partner SAM Program
PRESS RELEASE published on 09/12/2023 at 16:00, 2 years 2 months ago Anglepoint Hosts Companywide and Client Advisory Board Meetings in Las Vegas
PRESS RELEASE published on 03/23/2023 at 14:05, 2 years 8 months ago Anglepoint Launches ServiceNow App: IBM Licensing for Software Asset Management
Published on 12/05/2025 at 02:35, 3 hours 25 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 55 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 30 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 9 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 35 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 45 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 50 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 15 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 59 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
